Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

CYP3A4 gene polymorphisms influence testosterone 6beta-hydroxylation.

Norie Murayama1, Takahiro Nakamura, Mayumi Saeki

  • 1Project Team for Pharmacogenetics, National Institute of Health Sciences, Tokyo, Japan. nmurayam@nihs.go.jp

Drug Metabolism and Pharmacokinetics
|December 25, 2004
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development of human monoclonal antibodies against TARM1 by yeast display.

FEBS open bio·2026
Same author

Pharmacophore-Based Structure Optimization of <i>S</i>‑Trityl‑l‑Cysteine Derivatives for Cytotoxic Payload Applications.

ACS medicinal chemistry letters·2025
Same author

Isolation of a Monoclonal Human scFv Against Cytomegalovirus pp71 Antigen Using Yeast Display.

Antibodies (Basel, Switzerland)·2025
Same author

Identification of antimitotic sulfonamides inhibiting chromosome congression.

Biochemical pharmacology·2024
Same author

Clinical Profiles of Japanese Patients with Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis Collected by a Nationwide System from 2006 to 2023.

Biological & pharmaceutical bulletin·2024
Same author

JPH203, a LAT1 inhibitor, alleviates steroid-resistant murine airway inflammation mediated by Th17 cells.

Allergy·2023

Three single nucleotide polymorphisms (SNPs) in the CYP3A4 gene were studied. The T363M and T185S variants showed reduced testosterone hydroxylation and protein levels, suggesting impacts on CYP3A4 expression or stability.

Area of Science:

  • Pharmacogenomics
  • Enzyme kinetics
  • Molecular biology

Background:

  • CYP3A4 is a crucial enzyme in drug metabolism.
  • Single nucleotide polymorphisms (SNPs) in CYP3A4 can alter enzyme activity.
  • Limited information exists on the functional impact of specific CYP3A4 variants, particularly T185S.

Purpose of the Study:

  • To investigate the functional effects of three non-synonymous CYP3A4 SNPs (T185S, L293P, T363M) on testosterone hydroxylation.
  • To determine the impact of these polymorphisms on CYP3A4 protein expression and stability.

Main Methods:

  • Utilized a mammalian expression system to express wild-type and variant CYP3A4.
  • Measured testosterone hydroxylation activities (6beta-, 2beta-, 15beta-) for each variant.
  • Analyzed protein levels using Western blotting and mRNA levels using Northern blotting.

Related Experiment Videos

Main Results:

  • CYP3A4 variants T363M and T185S exhibited significantly reduced testosterone hydroxylation activities (<40% and <60%, respectively) compared to wild-type.
  • The L293P variant showed similar testosterone hydroxylation activities to the wild-type.
  • Western blot analysis revealed lower protein expression for T363M and T185S variants, while Northern blot analysis showed no significant difference in mRNA levels.

Conclusions:

  • The T363M and T185S substitutions in CYP3A4 likely affect protein expression or stability, leading to reduced enzyme activity.
  • These findings contribute valuable information on CYP3A4 genetic variations in the Japanese population.
  • Understanding these SNP effects is crucial for personalized medicine and predicting drug metabolism.